Gefitinib
CAS: 184475-35-2
Ref. TM-T1181
| 1g | 80.00 € | ||
| 5g | 144.00 € | ||
| 100mg | 54.00 € | ||
| 500mg | 62.00 € | ||
| 1ml*10 (DMSO) | 54.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Product Information
Name:
Gefitinib
Synonyms:
- ZD1839
- (3-Chloro-4-fluorophenyl)[7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-yl]amine
- 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline
- 4-(3′-Chloro-4′-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline
- 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-
- Akos 91371
- Gefitinib Base
- Gefitinib(TINIBS)
- Gefitinib, Iressa, ZD1839
- Gefonib
- See more synonyms
- Geftinib
- N-(3-Chloro-4-Fluoro-Phenyl)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)Quinazolin-4-Amine
- N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine
- N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine
- Zd 1839
- Zd1839
CAS:
Description:
Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations. Gefitinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell lung cancers. Gefitinib administration RESULTS in the development of the EGFR C797S resistance mutation.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
446.9
Formula:
C22H24ClFN4O3
Purity:
100%
Color/Form:
Light-Yellow Crystalline Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T1181 Gefitinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
